Skip to main content
Andrew Mammen, MD, Neurology, Baltimore, MD

AndrewLMammenMD

Neurology Baltimore, MD

Neuromuscular Medicine, Neurophysiology

Adjunct Associate Professor of Neurology, Adjunct Assistant Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Mammen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mammen's full profile

Already have an account?

  • Office

    4940 Eastern Ave
    Baltimore, MD 21224
    Phone+1 410-550-5624

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 2004 - 2005
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 2001 - 2004
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 2000 - 2001
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2000

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2004 - 2025
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Press Mentions

  • Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing Myopathy
    Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing MyopathyJune 4th, 2019
  • Update on Myositis
    Update on MyositisOctober 25th, 2018
  • Atorvastatin-Induced Necrotizing Autoimmune Myositis: An Emerging Dominant Entity in Patients with Autoimmune Myositis Presenting with a Pure Polymyositis Phenotype
    Atorvastatin-Induced Necrotizing Autoimmune Myositis: An Emerging Dominant Entity in Patients with Autoimmune Myositis Presenting with a Pure Polymyositis PhenotypeJanuary 23rd, 2017
  • Join now to see all

Professional Memberships